Bioelectric Research

Introducing ODIN 1® the new FDA-cleared bioelectric device to treat pain in a whole new way

2012 FDA 510(k) Clearance

Read about the FDA 510(k) Clearance of the ODIN 1® by the FDA.

Download the PDF
press release here

Clinical Trial Pipeline

Our recent indication for pain relief is just the start of what's to come. Learn more about research and development for potential ODIN 1® applications.

New Clinical Trial In Progress

Patient enrollment begins January 2016. For details see Clinicaltrials.gov

See More

This device is a prescription device and may only be used under the order of a licensed provider.

Adverse Reactions

Patients may experience skin irritation beneath the electrodes applied to the skin. Patients should stop using the device and consult their physicians if they experience adverse reactions from the device.

Contraindications

Do not use this device on patients who have:

  • A cardiac or demand-type pacemaker, implanted defibrillator, or other implanted metallic electronic device, because this may cause electric shock, burns, electrical interference, or death
  • Pregnancy
  • Known neoplasm

Device should not be applied over the carotid sinus nerves, particularly in patients with known sensitivity to the carotid sinus reflex.

For complete prescribing information, please see the user's manual.